Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

December 31, 2024

Conditions
Neurodegenerative Diseases
Interventions
DRUG

SMARTO ONE

The SMARTO ONE® small molecule natural flavonoid compound product is provided by Beijing Jiafurui Biological Technology Co., Ltd. The intervention agent formula consists of extracts from Polygonum cuspidatum leaves, Fructus ligustri lucidi, Prunus mume, Semen ziziphi spinosae, celery, resistant maltodextrin, and steviol glycoside. Each package of the test product (3g) contains a total flavonoid content of 150mg.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mei Han

OTHER